ACADIA Pharmaceuticals (ACAD)
(Real Time Quote from BATS)
$15.69 USD
-0.60 (-3.68%)
Updated Sep 24, 2024 02:04 PM ET
3-Hold of 5 3
B Value A Growth F Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.11 |
EPS Last Quarter | 0.20 |
Last EPS Surprise | 25.00% |
ABR | 1.80 |
Earnings ESP
|
-26.53% |
---|---|
Current Year | 0.52 |
Next Year | 0.85 |
EPS (TTM) | 0.18 |
P/E (F1) | 31.45 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 249.84M | 257.26M | 954.92M | 1.05B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 254.20M | 262.00M | 964.00M | 1.09B |
Low Estimate | 247.34M | 254.84M | 950.63M | 1.02B |
Year ago Sales | 211.70M | 231.04M | 726.44M | 954.92M |
Year over Year Growth Est. | 18.02% | 11.35% | 31.45% | 9.70% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.11 | 0.12 | 0.52 | 0.85 |
# of Estimates | 9 | 7 | 10 | 9 |
Most Recent Consensus | 0.08 | 0.11 | 0.65 | 0.77 |
High Estimate | 0.22 | 0.23 | 0.75 | 1.21 |
Low Estimate | -0.07 | 0.05 | 0.35 | 0.54 |
Year ago EPS | -0.40 | 0.28 | -0.37 | 0.52 |
Year over Year Growth Est. | 127.50% | -57.14% | 240.54% | 64.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 0 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 0 |
Down Last 60 Days | 5 | 5 | 5 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.11 | 0.12 | 0.52 | 0.85 |
7 Days Ago | 0.11 | 0.12 | 0.52 | 0.85 |
30 Days Ago | 0.12 | 0.12 | 0.52 | 0.85 |
60 Days Ago | 0.13 | 0.16 | 0.58 | 1.04 |
90 Days Ago | 0.13 | 0.16 | 0.58 | 1.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.08 | 0.11 | 0.52 | 0.77 |
Zacks Consensus Estimate | 0.11 | 0.12 | 0.52 | 0.85 |
Earnings ESP | -26.53% | -10.47% | 0.00% | -9.88% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.20 | 0.10 | 0.28 | -0.40 | NA |
Estimate | 0.16 | 0.04 | 0.32 | -0.43 | NA |
Difference | 0.04 | 0.06 | -0.04 | 0.03 | 0.02 |
Surprise | 25.00% | 150.00% | -12.50% | 6.98% | 42.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more